Calcineurin subunit B upregulates β-interferon production by phosphorylation of interferon regulatory factor 3 via toll-like receptor 4

Cancer Science

Volumn 103, Issue 3, 2012, Pages 515-521

  Wang, Xinyu ^a   Li, Li ^a   Huang, Yi ^a   Weil, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CALCINEURIN; CALCINEURIN SUBUNIT B; CYTOKINE; I KAPPA B ALPHA; INTERFERON REGULATORY FACTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCINEURIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84874089464     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02160.x     Document Type: Article

References (39)

1. Tseng P-H, Matsuzawa A, Zhang W, Mino T, Vignali DAA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol 2010; 11: 70-6.
2. Ikeda K, Arase Y, Saitoh S et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-32.
3. Decker T, Muller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 2005; 5: 675-87.
4. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1988; 273: 13367-70.
5. Kissinger CR, Parge HE, Knighton DR et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995; 387: 641-4.
6. Wu X, Nguyen BC, Dziunycz P et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 2010; 465: 368-72.
7. Saeki M, Irie Y, Ni L et al. Calcineurin potentiates the activation of procaspase-3 by accelerating its proteolytic maturation. J Biol Chem 2007; 282: 11786-94.
8. Liu J, Zhu JK. A calcium sensor homolog required for plant salt tolerance. Science 1998; 280: 1943-5.
9. + transporter AKT1 in Arabidopsis. Cell 2006; 125: 1347-60.
10. Wei Q, Lee EY. Expression and reconstitution of calcineurin A and B subunits. Biochem Mol Biol Int 1997; 41: 169-77.
11. Wei Q, Lian ML, Jing FZ et al. Studies of calcineurin B subunit from genetic engineering for use in medicine. Drug Develop Res 2002; 56: 40-3.
12. Li J, Guo J, Su Z, Hu M, Liu W, Wei Q. Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant. Int Immunol 2011; 23: 327-34.
13. An HZ, Hou J, Zhou J et al. Phosphatase SHP-1 promotes TLR- and RIG-Iactivated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 2008; 9: 542-50.
14. Qin BY, Liu C, Lam SS et al. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Mol Biol 2003; 10: 913-21.
15. Kim HM, Park BS, Kim JI et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 2007; 130: 906-17.
16. Lin R, Lu G, Wang J et al. Time course of gene expression profiling in the liver of experimental mice infected with Echinococcus multilocularis. PLoS ONE 2011; 6: e14557.
17. Ikeda K, Arase Y, Saitoh S et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-33.
18. Ricour Cl, Borghese F, Sorgeloos Fdr, Hato SV, Kuppeveld FJMv, Michiels T. Random Mutagenesis Defines a Domain of Theiler's Virus Leader Protein That Is Essential for Antagonism of Nucleocytoplasmic Trafficking and Cytokine Gene Expression. J Virol 2009; 83: 11223-32.
19. Chiang S-H, Bazuine M, Lumeng CN et al. The protein kinase IKKe regulates energy expenditure, insulin sensitivity and chronic inflammation in obese mice. Cell 2009; 138: 961-75.
20. Barro M, Patton JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci USA 2005; 102: 4114-9.
21. Poltorak A, He X, Smirnova I et al. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: mutations in Tlr4 Gene. Science 1998; 282: 2085-8. 22 Sakaguchi S, Negishi H, Asagiri M et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306: 860-6.
22. Sakaguchi S, Negishi H, Asagiri M et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306: 860-6.
23. Fitzgerald KA, McWhirter SM, Faia KL et al. IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-7.
24. Gaynor RB, Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K. TAK1 is critical for I kappa B kinase-mediated activation of the NF-kappa B pathway. J Mol Biol 2003; 326: 105-15.
25. Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 2011; 79: 34-41.
26. Doyle SE, Vaidya SA, O'Connell R et al. IRF3 Mediates a TLR3/TLR4- Specific Antiviral Gene Program. Immunity 2002; 17: 251-63.
27. Jin FZ, Lian ML, Wang X, Wei Q. Studies of the anticancer effect of calcineurin B. Immunopharmacol Immunotoxicol 2005; 27: 199-210.
28. Oganesyan G, Saha SK, Guo BC et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006; 439: 208-11.
29. Hacker H, Redecke V, Blagoev B et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006; 439: 204-7.
30. Sato M, Suemori H, Hata N et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000; 13: 539-48.
31. Berube J, Bourdon C, Yao Y, Rousseau S. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal 2009; 21: 448-56.
32. Yoshizawa T, Hammaker D, Sweeney SE, Boyle DL, Firestein GS. Synoviocyte Innate Immune Responses: I. Differential Regulation of Interferon Responses and the JNK Pathway by MAPK Kinases. J Immunol 2008; 181: 3252-8.
33. Sayama K, Hanakawa Y, Nagai H et al. Transforming growth factor-betaactivated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis. J Biol Chem 2006; 281: 22013-20.
34. Yen JH, Ganea D. Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 2009; 114: 1344-54.
35. Shibata S, Okano S, Yonemitsu Y et al. Induction of Efficient Antitumor Immunity Using Dendritic Cells Activated by Recombinant Sendai Virus and Its Modulation by Exogenous IFN-beta Gene. J Immunol 2006; 177: 3564-76.
36. Qin XQ, Tao N, Dergay A et al. Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice. Proc Natl Acad Sci USA 1998; 95: 14411-6.
37. Teige I, Treschow A, Teige A et al. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 2003; 170: 4776-84.
38. Gay NJ, Gangloff M. Structure and function of toll receptors and their Ligands. Annu Rev Biochem 2007; 76: 141-65.
39. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Protein 2001; 11: 725-32.